Royal College of Psychiatrists Annual Meeting. Manchester, UK. September 11 th 2013.
|
|
- William Summers
- 6 years ago
- Views:
Transcription
1 Dr Ben Sessa MBBS BSc MRCPsych Substance Misuse Services, Addaction, North Somerset, UK Honorary Senior Research Fellow, Cardiff University Medical School Royal College of Psychiatrists Annual Meeting. Manchester, UK. September 11 th
2 What are Psychedelic Drugs? Classical psychedelics(5-ht2a receptor partial agonists) LSD, Psilocybin, DMT, Mescaline Entactogens (Serotonin receptor agonists) MDMA, MDA, MMDA etc Dissociative anaesthetics (NMDA-antagonists) Ketamine, PCP THC (Cannabinoid receptor agonist) Ibogaine (Nicotinic receptor antagonist) Salvia Divinorum (Kappa-Opioid receptor agonist)
3 What are Psychedelic Drugs? Tryptamines serotonin DMT psilocybin LSD ibogaine Phenethylamines mescaline MDMA
4 Cross-cultural and archaic use of hallucinogens: 4
5 Psychedelic Research Applications and Potentials Neuroscience Creativity Meditation/Spir ituality Psychotherapy Addictions End-of-life issues PTSD
6 The discovery of LSD Dr Albert Hofmann Swiss Chemist First synthesised LSD in 1938 Discovered psychedelic properties in 1943 Campaigned for medical uses for psychedelics until his death aged 102 years 6
7 Early Medical Uses for LSD 1. Psychotomimetic 2. Self-experimentation by mental health professionals 3. Psychedelic Psychotherapy High dose single drug session Mystical / Peak experience Favoured in the US 4. Psycholytic Psychotherapy Low doses Frequent, regular sessions Favoured in the UK 7
8 Pioneers of the British Psychedelic Movement: 8
9 Ronald Sandison: British Psychiatrist and Psychoanalyst Ronald David Laing: Advice for those wishing to become a psychoanalyst: 1. Read the works of Freud 2. Undergo persaldous Huxley and Humphrey Osmond: Two very British intellectuals 3. onal analysis 4. Take LSD To make this trivial world sublime Take a half a gramme of phanerothyme To sink in hell or soar angelic You ll need a pinch of psychedelic 9
10 How do classical psychedelics work clinically? Disinhibition Loosening of the ego Access to the unconscious Repressed memories Can be worked through in real time o Non-directive, supporting emerging experience o Alternating inner focus & talking to therapists o Encouraged to fully experience and express whatever arises rather than avoiding or suppressing Creation of positive set and setting Preparation for sessions Use of breath, music and therapeutic touch Follow-up and integration 10
11 Dr. Stanislav Grof LSD is to the study of the mind what the telescope is to astronomy and the microscope is to biology.
12 "Treatment with LSD is not without acute adverse reactions, but given adequate psychiatric supervision and proper conditions for its administration, the incidence of such reactions is not great," Meta-analyses in the 1960s: 44 psychiatrists, 5000 subjects and 25,000 drug sessions: Rate of psychosis: 0.2% Rate of suicide of 0.04% (Cohen S. (1960) LSD: side effects and complications. Journal of Nervous and Mental Disorders 130: 30-40) 700 psychedelic drug sessions: One case of prolonged psychosis (Chandler Al. & Hartman Ma. (1960) LSD-25 as a Facilitating Agent in Psychotherapy. AMA Arch Gen Psychiatry; 2(3): ) 350 patients over four years of outpatient treatments: One attempted suicide (Ling TM, Buckman J (1963) The Treatment of Anxiety with Lysergic Acid and Methylphenidate. Practitioner 191: 201-4) Review of 20 years of psychedelic therapy in the UK, 4000 patients and 50,000 psychedelic drug-assisted sessions. Two completed suicides Thirty-seven patients with a prolonged psychosis (Malleson, N. (1971) Acute Adverse Reactions to LSD in clinical and experimental use in the UK. Br J Psychiatry. 18(543):229-30)
13 Risks when using classical psychedelics clinically Physiological risks Psychosis and Suicide Dependency risks Low Low Low Hallucinogen Persisting Perception Disorder (HPPD) Rare
14 BUT. Despite the safe and efficacious results of classical psychedelics used in the clinical setting in the context of the subsequent 1960s explosion of recreational drug use LSD is banned in 1966 and virtually all research stops. 14
15 3,4 Methylenedioxymethamphetamine (MDMA) Short acting (two to five hours) Minimal perceptual distortions Almost always pleasurable Empathogenic Safe in therapeutic applications Easier than LSD to control clinically Allows user to access repressed traumatic memories without being overwhelmed by the usual negative affect
16 Use of MDMA in the 1970s and 80s Used by 1960s psychedelic therapists when LSD was banned Couples Therapy Became scheduled in 1985 Particularly good for PTSD Greer, G. (1985) Using MDMA in psychotherapy. Advances: Journal of the Institute for the Advancement of Health, 2 (2), 57-59
17 The clinical burden of PTSD The lifetime prevalence between 6% and 10% Up to 15% in combat countries Very disabling Polypharmacy common High rates of self-harm and suicide Poor engagement on psychological inputs 50% treatment resistance 17
18 Could MDMA be the perfect agent for psychotherapy? Receptors or site in the brain: Increased Serotonin: 5-HT 1A 5-HT 1B Psychological effects: depression anxiety fear (at the amygdala) aggression and defensiveness self-confidence Why this helps with psychotherapy: Less anxiety and aggression improves relationship with therapist Allows patient to focus on trauma without being overwhelmed by negative affect 5-HT 2A Alterations in perception of meaning Facilitates new ways of thinking of old experiences Increased Dopamine and Norepineprine level of alertness arousal conscious registration of external stimuli (at LC) Improved behavioural readiness Improved recall of state-dependent memories of stressful events Provides Optimum Arousal Zone Increased alpha-2 activity calmness and relaxation Provides improved mental state for exploring negative cognitions Provides Optimum Arousal Zone At the hypothalamus Release of oxytocin Improved attachment with therapist Improved empathy and closeness Sessa, B. (2012) 1 Could MDMA be useful in the treatment of PTSD? Progress in Neurology and Psychiatry. Volume 15, Issue 6, pages 4 7, November/December 2011
19 Contemporary MDMA-Assisted psychotherapy for PTSD study Mithoefer et al (2013) Durability of Improvement in PTSD Symptoms and absence of harmful effects or drug dependency after MDM-assisted Psychotherapy: A Prospective Long-Term Follow-up Study. J. of Psychopharmacol, :28-39.
20 Is MDMA dangerous for humans? Early animal studies unsound Selection bias and confounding factors if investigating human ecstasy users Toxicity argument irrelevant to clinical propositions Highly politicized debate: Flawed studies, government restrictions The Risk-Benefit argument 20
21 Psychedelics as tools for treating addictions 21
22 Psychedelics as tools for addictions "The only cure for Dipsomania is Religiomania William James, The Varieties of Religious Experience, 1902 Peak Experience Sobriety It is a generally acknowledged fact in spiritual development that ego reduction makes the influx of God s grace possible. If, therefore, under LSD we can have a temporary reduction, so that we can better see what we are and where we are going well, that might be of some help. The goal might become clearer. So I consider LSD to be of some value to some people, and practically no damage to anyone. - Bill Wilson, Founder of Alcoholics Anonymous
23 Psychedelics as tools for addictions Personality Change Organic Psychosis (DTs) Peak Experience Sobriety Psychedelic Experience
24 Psychedelics as tools for addictions LSD for alcoholism Meta-Analysis Krebs, T.S and Johansen, P.O. (2012) Lysergic acid diethylamide (LSD) for alcoholism: a meta-analysis of randomized controlled trials. Journal of Psychopharmacology, 9 March 2012 Review of psychedelic treatments for addictions Bogenschutz, M. P. & Pommy, J. A. (2012) Re-Examining the Therapeutic Potential of Classical Hallucinogens in the Treatment of Addictions. Drug Testing and Analysis Drug Testing and Analysis 4 (7-8) Double-Blind RCT for Ketamine-Assisted Psychotherapy for alcohol and Opiate addictions Krupitsky, E.M. & Grinenko, A.Y. (1997). Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. Journal of Psychoactive Drugs 29 (2):
25 Contemporary Psychedelic Research: Completed Studies DMT human dose-response study Strassman,R.J. (1996) Human psychopharmacology of N,N-dimethyltryptamine. Behav. Brain Res.73, ) Ketamine to treat Alcohol Dependence Krupitsky, E.M. & Grinenko, A.Y. (1997). Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. Journal of Psychoactive Drugs 29 (2): Psilocybin to treat Obsessive Compulsive Disorder Moreno FA, Wiegand CB, Taitano EK & Delgado PL. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.. J Clin Psychiatry. 2006;67: ) Psilocybin and the Spiritual Experience Griffiths, R.R., Richards, W.A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187, MDMA to treat PTSD Mithoefer et al (2013) Durability of Improvement in PTSD Symptoms and absence of harmful effects or drug dependency after MDMA-assisted Psychotherapy: A Prospective Long-Term Follow-up Study. J Psychopharmacol, :28-39 Psilocybin to treat Anxiety in end-stage cancer Grob, C., Chopra, A.L. Danforth, M.C. Hagerty, C.R. McKay, A.L. Halberstadt, and G.R. Greer (2010) Pilot Study of Psilocybin Treatment for Anxiety in Advanced-stage Cancer Patients [with G.S.].Arch Gen Psychiatry, 68(1):71-78 LSD to treat Anxiety in end-stage cancer Gasser, P. 25
26 Further Studies Underway MDMA Therapy for PTSD in War Veterans, USA MDMA Therapy for PTSD for Boulder, USA MDMA Therapy for PTSD Israel MDMA Therapy for PTSD Canada Psilocybin-Assisted Psychotherapy for nicotine addiction, NYU, USA Psilocybin-Assisted Psychotherapy for alcohol addiction, Psilocybin-Assisted Psychotherapy for end-stage cancer, Johns Hopkins, USA Psilocybin-Assisted Psychotherapy for end-stage cancer, Johns Hopkins, USA Ibogaine Therapy as a treatment for addictions, San Diego, USA Ayahuasca Therapy as a treatment for addictions, Canada
27 Contemporary Psychedelic Research in the UK Bristol Psilocybin Project 2009 Imperial Psilocybin Project 2012 Imperial MDMA fmri Project 2012 Imperial Depression Psilocybin 2014 Cardiff MDMA for PTSD 2014 Oxford Ketamine Project 2012 Imperial LSD Creativity Project
28 The Cardiff MDMA project Ben Sessa, Mat Hoskins and Jon Bisson Cardiff University Hospital Medical School CUBRIC, MAPS and Imperial University, London Double-blind, placebo controlled crossover fmri study of combat veterans with chronic treatment-resistant PTSD. Twenty-four subjects will receive two fmri scans; one with 125mg of MDMA and a second, two weeks later, with an inactive placebo. Measure the neurobiological correlates of MDMA vs. Placebo using four behavioural paradigms, which relate directly to the symptoms of PTSD. Recall of autobiographical memories Social judgements paradigm Exposure to fearful faces Traumatic script cue paradigm. Participants recruited from the University Hospital of Wales Veterans Service, screened according to safety and diagnostic suitability criteria and randomly allocated into one of two groups.
29 Contemporary Renaissance of Psychedelic Research: 29
30
31
32 The Forefather of Psychedelic Therapy in Britain? The future may teach us how to exercise a direct influence, by means of particular chemical substances, upon the neural apparatus. It may be that there are other still undreamt of possibilities of therapy. From An Outline of Psychoanalysis Sigmund Freud London 1938.
Forward for the Future of Psychiatry
Dr. Ben Sessa MD Child and Adolescent Psychiatrist MDMA Researcher at Bristol and Imperial College London Universities, UK Psychedelics, MDMA, Trauma and Addictions: Bold Steps 5th Meeting of the World
More informationThe Benefits of Psychedelic Drug Application for Clinical Treatment of Mental Illness. Timothy Shumate. The University of Kansas School of Nursing
The Benefits of Psychedelic Drug Application for Clinical Treatment of Mental Illness Timothy Shumate The University of Kansas School of Nursing About the author: Tim Shumate is from Wichita, Kansas. He
More informationTHE CUTTING EDGE IN ANXIETY AND DEPRESSION TREATMENT. scott shannon, md university of colorado
THE CUTTING EDGE IN ANXIETY AND DEPRESSION TREATMENT scott shannon, md university of colorado DISCLOSURES I have published two textbooks on integrative mental health. I have published two books on parenting
More informationESALEN INSTITUTE CONTINUING EDUCATION PSYCHOLOGY, MFT/LCSW, LPC, LEP, RN
ESALEN INSTITUTE CONTINUING EDUCATION PSYCHOLOGY, MFT/LCSW, LPC, LEP, RN Leader Name/s: David Presti & Kristi Panik Workshop Title: Psychedelic Medicines and the Mind Workshop Description: Psychedelics
More informationTherapeutic potential of psychedelics in substance use disorders
Therapeutic potential of psychedelics in substance use disorders Randy T Brown MD, PhD, FASAM Associate Professor randy.brown@fammed.wisc.edu Conflicts of Interest Statement No conflicts of interest to
More informationHallucinogens as Treatment? Preliminary Data with Ketamine. Elias Dakwar, MD Columbia University College of Physicians and Surgeons 19 October, 2017
Hallucinogens as Treatment? Preliminary Data with Ketamine Elias Dakwar, MD Columbia University College of Physicians and Surgeons 19 October, 2017 Disclosures Elias Dakwar has received funding from NIDA
More informationErowid Wisdom Cycle Survey #1 April 15, 2013
Erowid Wisdom Cycle Survey #1 April 15, 2013 Purpose This survey is part of a project to gather wisdom and life lessons related to the use of psychedelics, empathogens, and cannabis. In part, we are exploring
More informationResearch News. Treating PTSD with MDMA-Assisted Psychotherapy. mdmaptsd.org
Research News Treating PTSD with MDMA-Assisted Psychotherapy mdmaptsd.org 20th Subject Treated in Ongoing Veterans Study; Study Fully Funded Ongoing study Location: Charleston, South Carolina Principal
More informationTreating PTSD with MDMA-Assisted Psychotherapy
Treating PTSD with MDMA-Assisted Psychotherapy One out of three people suffering from posttraumatic stress disorder (PTSD) do not respond adequately to treatment. Can MDMA-assisted psychotherapy help?
More informationThe Healing Potential of MDMA
The Healing Potential of MDMA Amy Emerson Director of Clinical Research Multidisciplinary Association for Psychedelic Studies TRI March, 2014 PTSD Traumatic event Event passes, fearful memories remain
More informationBack to the Future: Psilocybin Trials in Treatment Resistant Depression in the UK.
Back to the Future: Psilocybin Trials in Treatment Resistant Depression in the UK. James Rucker MBBS BSc MRCPsych PhD Consultant Psychiatrist. South London & Maudsley NHS Trust Senior Clinical Lecturer
More informationThis is Your Brain on LSD
This is Your Brain on LSD Kayla Ortiz Rafael Yitzhakian What is LSD? What is LSD? LSD (acid) Lysergic acid diethylamide Hallucinogenic drug Serotonergic psychedelic Banned in the U.S. in the 60 s Classified
More informationFar Out Therapies: Psychedelics in Palliative Care. By Dr. Hayden Rubensohn
Far Out Therapies: Psychedelics in Palliative Care By Dr. Hayden Rubensohn Disclosures Dr. Rubensohn is a paid research therapist for the Multidisciplinary Association for Psychedelic Studies (MAPS); affiliated
More informationStates of Consciousness
Myers PSYCHOLOGY (7th Ed) Chapter 7 States of Consciousness Waking Consciousness Consciousness our awareness of ourselves and our environments Sleep and Dreams Biological Rhythms periodic physiological
More informationCONSCIOUSNESS AND THE TWO-TRACK MIND
Chapter 3 CONSCIOUSNESS AND THE TWO-TRACK MIND Forms of Consciousness Modern psychologists believe that consciousness is an awareness of ourselves and our environment. Consciousness is not whether or not
More informationPsychotropic Drugs Critical Thinking - KEY
Open Your Class with This Tomorrow Chasing the Scream: The First and Last Days of the War on s Psychotropic s Critical Thinking - KEY Background: The blood-brain barrier is a network of tightly packed
More informationUnderground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary
Article Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary Drug Science, Policy and Law 2(0) 1 8! The Author(s) 2015 Reprints
More informationGlencoe Health. Lesson 3 Psychoactive Drugs
Glencoe Health Lesson 3 Psychoactive Drugs Health espotlight Video BIG IDEA Psychoactive drugs affect the central nervous system and can be especially damaging to the developing brain and body of a teen.
More informationWhat Are Hallucinogens? (National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services)
What Are Hallucinogens? (National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services) Hallucinogens are a diverse group of drugs that alter perception
More informationPSYCHEDELIC HEALING? Hallucinogenic drugs, which blew minds in the 1960s, soon may be used to treat mental ailments By David Jay Brown
66 SCIENTIFIC AMERICAN MIND December 2007/Januar y 2008 CREDIT PSYCHEDELIC HEALING? Hallucinogenic drugs, which blew minds in the 1960s, soon may be used to treat mental ailments By David Jay Brown M PHILIP
More informationPSYCHOLOGICAL DISORDERS CHAPTER 13 MEYERS AND DEWALL
PSYCHOLOGICAL DISORDERS CHAPTER 13 MEYERS AND DEWALL OVERVIEW What are Psychological Disorders? Anxiety Disorders, OCD, and PTSD Substance Use and Addictive Disorders Mood Disorders Schizophrenia Additional
More informationActivation-synthesis hypothesis. compulsive drug craving and use, despite adverse consequences. Addition. Amphetamines. Barbiturates.
Activation-synthesis hypothesis Suggests that in the brain engages in a lot of neural activity that is random. Dreams make sense of this activity. Addition compulsive drug craving and use, despite adverse
More informationOutline 3/5/2013. Practice Question. Practice question. PSYC 120 General Psychology. Spring 2013 Lecture 11: States of consciousness
Outline 3/5/2013 PSYC 120 General Psychology Spring 2013 Lecture 11: States of consciousness The Nature of Consciousness Sleep and Dreams Psychoactive Drugs Hypnosis Meditation Dr. Bart Moore bamoore@napavalley.edu
More informationMDMA-Assisted Psychotherapy for Treatment of Chronic PTSD: Findings from MAPS-Sponsored Phase 2 Clinical Research Trials
MDMA-Assisted Psychotherapy for Treatment of Chronic PTSD: Findings from MAPS-Sponsored Phase 2 Clinical Research Trials Allison Feduccia, Ph.D. Clinical Trial Leader MAPS Public Benefit Corporation www.maps.org
More informationStates of Consciousness Day 2
States of Consciousness Day 2 Hypnosis* l Hypnosis: involves a state of awareness characterized by deep relaxa6on, heightened sugges6bility, and focused a:en6on. l Hypno6st suggests changes in sensa6ons,
More informationA substance that reduces pain and may or may not have psychoactive properties.
GLOSSARY OF TERMS AMPHETAMINE-TYPE STIMULANTS (ATS) A group of substances, mostly synthetic, with closely related chemical structure which have, to varying degrees, a stimulating effect on the central
More informationPsychedelics. Neal Deot & Amir Hakimi
Psychedelics Neal Deot & Amir Hakimi Psychedelics Psychedelic comes from the Greek words psyche (soul) and delein (to manifest) = soul-manifesting Often compared to non-ordinary forms of consciousness:
More informationStates of Consciousness
Myers PSYCHOLOGY Unit 5 States of Consciousness "We do imagery work and talk about having that innovative mindset of being special," Wilson says. "We talk about being in the moment and increasing chaos
More informationChapter 3 Part 2: Tolerance, dependence, addiction, & types of drugs
Consciousness and the Two-Track Mind Chapter 3 Part 2: Tolerance, dependence, addiction, & types of drugs Unit 5 ~ AP Psychology ~ Ms. Justice 12: What are tolerance, dependence, and addiction, and what
More informationHALLUCINATIONS. Miren Edelstein PSYC182 December 10 th, 2014
HALLUCINATIONS Miren Edelstein PSYC182 December 10 th, 2014 What are hallucinations? Sensations and perceptions that appear real but are created by your mind (absence of an external stimulus) Stigma in
More informationMain Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
More informationRead the article, then answer the questions that follow. How MDMA Treats PTSD: Everything You Need to Know
Read the article, then answer the questions that follow. How MDMA Treats PTSD: Everything You Need to Know The party drug is entering the final stages of trials and could be approved for prescription use
More informationPsychoactive Drugs. Psychoactive drug: A chemical substance that alters perceptions and mood.
LP 5C Drugs and alcohol 1 Psychoactive Drugs Psychoactive drug: A chemical substance that alters perceptions and mood. Your textbook characterizes three broad categories of psychoactive drugs Depressants:
More informationPSYCHOACTIVE DRUGS. RG 5c
PSYCHOACTIVE DRUGS RG 5c TODAY S GOALS Can you Explain the difference between stimulants and depressants Identify the major psychoactive drug categories (e.g., depressants, stimulants) and classify specific
More informationLSD in Medicine. By Max Zundel and Emily O Connell
LSD in Medicine By Max Zundel and Emily O Connell What is LSD and how does it work? LSD - lysergic acid diethylamide Illegal street drug that can be found/bought in liquid, capsule, white powder, or tablet,
More informationBiology 3201 Nervous System #6: Effects of Drugs at Synapses
Biology 3201 Nervous System #6: Effects of Drugs at Synapses Toxins prevent the release of acetylcholine ex. Clostridium botulinum (botulism: muscle paralysis)/ Clostridium tetani (tetanus: a disease characterized
More informationPsychedelic Science. Curse or salvation?
Psychedelic Science Curse or salvation? We acknowledge the tradi1onal custodians of the land on which we meet today and pay respect to Elders past, present and emerging. We also extend that respect to
More informationTherapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
Review Received: 1 January 2012 Revised: 30 April 2012 Accepted: 30 April 2012 Published online in Wiley Online Library (www.drugtestinganalysis.com) DOI 10.1002/dta.1376 Therapeutic mechanisms of classic
More informationDrugs and the Brain. Sooren Moosavy and Vanessa Travieso
Drugs and the Brain Sooren Moosavy and Vanessa Travieso What are drugs? DRUG: any substance which, when ingested in relatively small amounts, induces a physiological change LD50 lethal dose 50% = dose
More informationClinical Toxicology: An Update
Clinical Toxicology: An Update Dr. Shaun Greene VICTORIAN POISONS INFORMATION CENTRE AND AUSTIN HOSPITAL CLINICAL TOXICOLOGY SERVICE Drug Abuse in Australasia VICTORIAN POISONS INFORMATION CENTRE AND AUSTIN
More informationEarly History: Ceremonial. The ghost in the machine? examining change phenomena in psychedelic assisted psychotherapy
Early History: Ceremonial The ghost in the machine? examining change phenomena in psychedelic assisted psychotherapy Andrew Penn, RN, MS, NP, APRN-BC Psychiatric Nurse Practitioner Kaiser Permanente Redwood
More informationCANNABINOIDS and HALLUCINOGENS
CANNABINOIDS and HALLUCINOGENS Cannabinoids Cannabis Most popular recreational drug in the US after alcohol and tobacco Possession and use illegal under federal law, but states have variable policies on
More informationNovel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA Michael C Mithoefer, Charles S Grob, Timothy D Brewerton 4-phosphorloxy-N,N-dimethyltryptamine (psilocybin) and methylenedioxymethamfetamine
More informationDr Rozmin H. BSc, MSc, PhD, DClinHyp, DClinPsych, CPsychol, AFBPSs. HCPC Registration No. PYL06448 DBS Registration No.
Dr Rozmin H BSc, MSc, PhD, DClinHyp, DClinPsych, CPsychol, AFBPSs HCPC Registration No. PYL06448 DBS Registration No. 001352397542 PROFESSIONAL QUALIFICATIONS & EXPERTISE Professional Qualification Chartered
More informationModule 22- Understanding Consciousness & Hypnosis
Module 22- Understanding Consciousness & Hypnosis - Fundamental, hard to define Psychological Concept - Difficulties in defining consciousness led those specializing in behaviorism to look at direct observations
More informationerapies
CHAPTER 24 Therapies 456. The analysis of a client s past experiences and suggestions for ways the client can overcome his or her problems that stem from these experiences is the basis for which type of
More informationPsilocybin-assisted therapy for depression. Peak experience, Amygdala changes
Psilocybin-assisted therapy for depression Peak experience, Amygdala changes Psilocybin-assisted therapy n = 20 Treatment resistant major depression Two doses of psilocybin (10mg & 25mg) separated by 1
More informationOutline 3/7/2013. Practice Question. Practice Question. PSYC 120 General Psychology. Spring 2013 Lecture 12: States of consciousness & Learning
PSYC 120 General Psychology Spring 2013 Lecture 12: States of consciousness & Learning Outline 3/7/2013 Consciousness: Psychoactive Drugs Hypnosis Meditation Learning Dr. Bart Moore bamoore@napavalley.edu
More informationI DON T KNOW WHY THEY CALL THIS ECSTASY
I DON T KNOW WHY THEY CALL THIS ECSTASY WHAT S GOING ON IN MDMA-ASSISTED PSYCHOTHERAPY FOR PTSD? Royal College of Psychiatrists Faculty of Medical Psychotherapy Annual Conference Cardiff, April 2018 Michael
More informationClasses of Neurotransmitters. Neurotransmitters
1 Drugs Outline 2 Neurotransmitters Agonists and Antagonists Cocaine & other dopamine agonists Alcohol & its effects / Marijuana & its effects Synthetic & Designer Drugs: Ecstasy 1 Classes of Neurotransmitters
More informationThe Royal College of Psychiatrists International Congress 2 5 July 2013 Provisional Programme
The Royal College of Psychiatrists International Congress 2 5 July 2013 Provisional Programme Tuesday, 2 July 9.00-9.30 Presidential Address: The place of doctor psychiatrists as leaders and innovators
More informationFundamentals of Psychopharmacology. Distribution of Receptors Influences Safety
Fundamentals of Psychopharmacology Matt Schalles UCSD Cognitive Science mdschalles@ucsd.edu Distribution of Receptors Influences Safety Opioid Receptors Cannabinoid Receptors 1 Brief History of Drug Advances
More informationThe Science of Addiction: Genetics and the Brain Webquest
The Science of Addiction: Genetics and the Brain Webquest Part 1: Click here to begin ( might need a laptop not ipad) Complete this chart. Focus on what you DON T REMEMBER FROM HEALTH CLASS. If you know
More informationStates of Consciousness
1 Unit 5 Review of Key Concepts and Terms States of Consciousness (2-4% of the AP exam/curriculum) Consciousness: our awareness of ourselves and our environment. Preconscious: something that is not in
More informationEffects of Ketamine on Healthy Participants and Individuals Suffering from Schizophrenia. John Smith. Physiological Foundations of Psychology 71733
Effects of Ketamine on Healthy Participants and Individuals Suffering from Schizophrenia John Smith Physiological Foundations of Psychology 71733 Long Beach City College, Spring 2002 Abstract The purpose
More informationCOMMENTARY. Charles R. Schuster
DOI 10.1007/s00213-006-0460-x COMMENTARY Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.
More informationRunning head: CLINICAL POTENTIAL FOR USE OF LSD AND MDMA IN TREATMENT OF TRAUMA HEALING HIGHS: THE CLINICAL POTENTIAL FOR THE USE OF LYSERGIC ACID
Running head: CLINICAL POTENTIAL FOR USE OF LSD AND MDMA IN TREATMENT OF TRAUMA HEALING HIGHS: THE CLINICAL POTENTIAL FOR THE USE OF LYSERGIC ACID DIETHYLMIDE (LSD-25) AND 3,4-METHYLENEDIOXY-METHAMPHETAMINE
More informationMyers Psychology for AP*
Myers Psychology for AP* David G. Myers PowerPoint Presentation Slides by Kent Korek Germantown High School Worth Publishers, 2010 *AP is a trademark registered and/or owned by the College Board, which
More informationOBJECTIVES PLAN OF LESSON
Unit: Behavioral Health Nursing Implementation:Keltner et al., Ch. 1, 2, 3, & Appendix; PowerPoint Presentation; Lesson: 1 Handouts; Lecture/Discussion; Transparencies Title: Historic Perspective of Mental
More informationMethylenedioxymethamphetamine (MDMA, or ecstasy ) stimulates the release of dopamine at low doses. At higher doses it also stimulates serotonin
Methylenedioxymethamphetamine (MDMA, or ecstasy ) stimulates the release of dopamine at low doses. At higher doses it also stimulates serotonin synapses, producing hallucinogenic effects similar to those
More informationThe Human Animal Drugs of Plant Origin
The Human Animal Drugs of Plant Origin Plant Secondary Compounds The Spice of Life Cultural Use of Spices Spice Use by Region 1 Silurian Land Plants History of Insect Damage 416-447 MYA Colonization of
More informationIn clinical research settings around the world,
CMAJ Early release, published at www.cmaj.ca on September 8, 2015. Subject to revision. Analysis Psychedelic medicine: a re-emerging therapeutic paradigm Kenneth W. Tupper PhD, Evan Wood MD PhD, Richard
More informationMyers Psychology for AP* David G. Myers PowerPoint Presentation Slides by Kent Korek Germantown High School Worth Publishers, 2010
Myers Psychology for AP* David G. Myers PowerPoint Presentation Slides by Kent Korek Germantown High School Worth Publishers, 2010 *AP is a trademark registered and/or owned by the College Board, which
More informationSpecial Topic: Drugs and the Mind
BIOLOGY OF HUMANS Concepts, Applications, and Issues Fifth Edition Judith Goodenough Betty McGuire 8a Special Topic: Drugs and the Mind Lecture Presentation Anne Gasc Hawaii Pacific University and University
More informationLSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
(2016) 41, 2638 2646 Official journal of the American College of OPEN www.neuropsychopharmacology.org LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality Patrick C Dolder
More informationBrain and Behavior Lecture 13
Brain and Behavior Lecture 13 Technology has improved our ability to know how the brain works. Case Study (Phineas Gage) Gage was a railroad construction foreman. An 1848 explosion forced a steel rod through
More informationa guide to cognitivebehavioural (cbt)
a guide to cognitivebehavioural therapy (cbt) Cognitive-behavioural aims to help you to change the way that you think, feel and behave. It is used as a treatment for various mental health and physical
More informationUnderstanding Alcohol And Other Drugs Of Abuse
Understanding Alcohol And Other Drugs Of Abuse Wilkie A. Wilson, Ph.D. DukeLEARN www.dukelearn.com Duke University Medical Center 1 We teach people to respect their hearts... Exercise Eat good food Reduce
More informationResearch News. Treating PTSD with MDMA-Assisted Psychotherapy. mdmaptsd.org
MAPS Bulletin Annual Report Research News Treating PTSD with MDMA-Assisted Psychotherapy mdmaptsd.org MAPS and MPBC staff and researchers will meet with the FDA on November 29, 2016. Phase 3 Trials: FDA
More informationInterpersonal Biofeedback Training with Couples
Couples Biofeedback Training using Alive Prepared by Somatic Vision, Inc., makers of Alive, May 2014 Pioneer Alive Pioneer enables couples to train together with both partners being measured simultaneously
More informationPERCEPTION: Gain Control & Integration. Mark A. Geyer, Ph.D. Departments of Psychiatry & Neurosciences University of California, San Diego
PERCEPTION: Gain Control & Integration Mark A. Geyer, Ph.D. Departments of Psychiatry & Neurosciences University of California, San Diego Perception Integration Integration: The processes linking the output
More informationJOHNS HOPKINS STUDY PROBES SACRED MUSHROOM CHEMICAL
Media Contact: Roland Griffiths, 410 550-0034 JOHNS HOPKINS STUDY PROBES SACRED MUSHROOM CHEMICAL Scientists seek dosage sweet spot, find positive effects lasting over a year Former U.S. Drug Czar raises
More informationHarms and benefits associated with psychoactive drugs: findings of an international survey of active drug users
477744JOP27610.1177/0269881113477744Journal of PsychopharmacologyMorgan et al. 2013 Original Paper Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug
More informationU.S. 1 February 22, 2013
U.S. 1 February 22, 2013 A Placebo-controlled, Randomized, Blinded, Dose Finding Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults Study Code: MAA-1 Sponsor: Multidisciplinary
More informationExploring the Therapeutic Potential of Psychedelics
SUURJ: Seattle University Undergraduate Research Journal Volume 2 Article 6 2018 Exploring the Therapeutic Potential of Psychedelics Xavier M. Hernandez Seattle University, hernan54@seattleu.edu Follow
More informationRecent Advances in the Treatment of Post Traumatic Stress Disorder. Jon Bisson School of Medicine Cardiff University
Recent Advances in the Treatment of Post Traumatic Stress Disorder Jon Bisson School of Medicine Cardiff University Agenda What are we treating Psychological approaches Pharmacological approaches Treatment
More informationContemporary Psychiatric-Mental Health Nursing Third Edition. Theories: Anxiety Disorders. Theories: Anxiety Disorders (cont'd) 10/2/2014
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 18 Anxiety Disorders Theories: Anxiety Disorders Biological changes in the brain Neurotransmitters are associated with anxiety. low
More informationLSD Revealed. The Royal Society - London. 13 April The Beckley/Imperial Research Programme. Co-directed by Amanda Feilding and David Nutt
PLACEBO LSD LSD Revealed The Royal Society - London 13 April 2016 The Beckley/Imperial Research Programme Co-directed by Amanda Feilding and David Nutt Lead Investigator Robin Carhart-Harris t The Beckley
More informationPsychedelic Drugs. Pharmacokinetics. Pharmacodynamics. Anticholinergic PNS. Psychedelics / Hallucinogens
Psychedelic Drugs Psychedelics / Hallucinogens Psychology 472 Pharmacology of Psychoactive Drugs Listen to the audio lecture while viewing these slides Many Types Broken out by the type of NT it affects
More informationBenzodiazepines: risks, benefits or dependence
Benzodiazepines: risks, benefits or dependence A re-evaluation Council Report CR 59 January 1997 Royal College of Psychiatrists, London Due for review: January 2002 1 Contents A College Statement 3 Benefits
More informationLong-Term Effects of Lysergic Acid Diethylamide (LSD) Use and Potential Medicinal Uses
Long-Term Effects of Lysergic Acid Diethylamide (LSD) Use and Potential Medicinal Uses Deana Fedaie Introduction Lysergic Acid Diethylamide (LSD) is a chemical compound that is commonly used as a recreational,
More informationThinking About Psychology: The Science of Mind and Behavior 2e. Charles T. Blair-Broeker Randal M. Ernst
Thinking About Psychology: The Science of Mind and Behavior 2e Charles T. Blair-Broeker Randal M. Ernst Cognitive Domain Consciousness Chapter Module 26 Drugs Module 26: Drugs Introduction Psychoactive
More informationSleep and Dreams. Sleep and Dreams. Brain Waves and Sleep Stages Typical Nightly Sleep Stages. Chapter 7 States of Consciousness
Chapter 7 States of Consciousness States of Consciousness Consciousness our awareness of ourselves and our environments Fantasy Prone Personality imagines and recalls experiences with lifelike vividness
More informationNeurology and Trauma: Impact and Treatment Implications Damien Dowd, M.A. & Jocelyn Proulx, Ph.D.
Neurology and Trauma: Impact and Treatment Implications Damien Dowd, M.A. & Jocelyn Proulx, Ph.D. Neurological Response to a Stressor Information from the senses goes to the thalamus which sends the information
More informationWorkshop I. Dialectical Behaviour Therapy Workshop Saturday March 12 th, About Dialectical Behaviour Therapy
Workshop I Dialectical Behaviour Therapy Workshop Saturday March 12 th, 2014 About Dialectical Behaviour Therapy Dialectical Behaviour Therapy, or DBT, is an innovative and comprehensive psycho-educational
More informationThe History of Psychedelics in Medicine
The History of Psychedelics in Medicine Ben Sessa Inhalt 1 Introduction... 2 2 The History of Psychedelics in Medicine... 2 3 Conclusions... 17 References... 18 Abstract Psychedelics have been used for
More informationContemporary Psychiatric-Mental Health Nursing. Theories: Anxiety Disorders. Theories: Anxiety Disorders - continued
Contemporary Psychiatric-Mental Health Nursing Chapter 18 Anxiety and Dissociative Disorders Theories: Anxiety Disorders Biological changes in the brain Noradrenergic system is sensitive to norepinephrine;
More informationLong-term follow-up of psilocybin-facilitated smoking cessation
THE AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE 217, VOL. 43, NO. 1, 55 6 http://dx.doi.org/1.319/95299.216.117135 ORIGINAL ARTICLE Long-term follow-up of psilocybin-facilitated smoking cessation Matthew
More informationKey Concepts in. Drugs and Society
Key Concepts in Drugs and Society 00-Coomber-Prelims.indd 1 31/01/2013 3:07:20 PM A drug is any psychoactive substance that can alter the way the mind or body works, regardless of legal status or medical
More informationICCAM platform. Introduction. David Nutt November 2011
ICCAM platform Introduction David Nutt November 2011 The ICCAM Platform New Drugs to Treat Addiction: Can a Knowledge of Brain Mechanisms Help? An MRC addiction cluster Imperial College London: David Nutt
More informationA handful of dangerous new legal drugs has public health experts worried
Page 1 of 8 A handful of dangerous new legal drugs has public health experts worried MATTHEW SPEISER AUG. 11, 2015, 5:00 PM Over the past 20 years, the drug world has seen the rise of new psychoactive
More informationPriory Hospital Ticehurst House
www.priorygroup.com TICEHURST HOUSE Priory Hospital Ticehurst House Expert mental health treatment Priory is the UK s leading provider of therapy and consultant-led mental health treatment. Every year,
More informationMDMA-assisted Psychotherapy for PTSD: An Update of Completed and Ongoing Research
MDMA-assisted Psychotherapy for PTSD: An Update of Completed and Ongoing Research Michael Mithoefer, MD, FAPA Private practice psychiatry & clinical research Clinical Assistant Professor of Psychiatry
More informationNorfolk & Suffolk Crime Prevention Guidance Note Legal Highs
Norfolk & Suffolk Crime Prevention Guidance Note Legal Highs What are legal highs? Legal highs that are actually legal contain one or more chemical substances which produce similar effects to illegal drugs
More information8/22/2016. Contemporary Psychiatric-Mental Health Nursing Third Edition. Theories: Anxiety Disorders. Theories: Anxiety Disorders (cont'd)
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 18 Anxiety Disorders Theories: Anxiety Disorders Biological changes in the brain Noradrenergic system is sensitive to norepinephrine;
More informationMAPS Study MP-10 1 Study Synopsis UK April 18, 2011
MAPS Study MP-10 1 Study Synopsis A Randomized, Triple-Blind, Phase 2 Pilot Study with an Open-Label Lead-in Comparing 3 Different Doses of MDMA in Conjunction with Manualized Psychotherapy in 20 Subjects
More informationTripping up addiction: The use of psychedelic drugs in the treatment of problematic drug and alcohol use
Tripping up addiction: The use of psychedelic drugs in the treatment of problematic drug and alcohol use Short Title: Illicit drugs in the treatment of addiction Celia Morgan 1,3, Amy McAndrew 1, Tobias
More informationWhat is Personality?
What is Personality? Free will or determinism? Masters of our own fate or biological, unconscious, external factors Nature or nurture? Heredity or environment Past, present, or future? Is it determined
More informationPerformance of Initiating Q South London and Maudsley NHS Foundation Trust:
16/LO/1102 177307 The Role of Nitric Oxide in Cognition in Schizophrenia: the NOC study 06/03/2017 22/04/2016 15/08/2016 15/08/2016 08/09/2016 08/09/2016 08/09/2016 Neither 16/LO/1299 200774 The development
More informationPerformance of Initiating Q South London and Maudsley NHS Foundation Trust:
By of First 16/LO/1439 212222 16/EE/0318 201898 16/LO/0873 193362 16/EE/0233 188916 16/LO/1862 206680 A pilot study of two sessions responsibility intervention for auditory hallucinations A randomised
More information